BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 6702873)

  • 1. Neutropenia, fever, and infection.
    Brown AE
    Am J Med; 1984 Mar; 76(3):421-8. PubMed ID: 6702873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combating infections in neutropenic patients.
    Pizzo PA
    Hosp Pract (Off Ed); 1989 Jul; 24(7):93-100, 103-4, 107-10. PubMed ID: 2501330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Empirical therapy for bacterial infections in neutropenic patients.
    Klastersky J
    Support Care Cancer; 1994 Nov; 2(6):347-54. PubMed ID: 7858926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Causative pathogens of fever in neutropenic patients at King Chulalongkorn Memorial Hospital.
    Roongpoovapatr P; Suankratay C
    J Med Assoc Thai; 2010 Jul; 93(7):776-83. PubMed ID: 20649055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Septicaemia caused by viridans streptococci in neutropenic patients with leukaemia.
    Cohen J; Donnelly JP; Worsley AM; Catovsky D; Goldman JM; Galton DA
    Lancet; 1983 Dec 24-31; 2(8365-66):1452-4. PubMed ID: 6140545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stopping antibiotic therapy in neutropenic patients.
    DiNubile MJ
    Ann Intern Med; 1988 Feb; 108(2):289-92. PubMed ID: 3341657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bacterial sepsis in the hematologic neutropenic patient].
    Todeschini G; Benato G; Carlini S; Veneri D
    Haematologica; 1989 Oct; 74(5 Suppl):297-309. PubMed ID: 2480272
    [No Abstract]   [Full Text] [Related]  

  • 8. Teicoplanin in combination therapy for febrile episodes in neutropenic and non-neutropenic paediatric patients.
    Lemerle S; de La Rocque F; Lamy R; Fremaux A; Bernaudin F; Lobut JB; Reinert P
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():113-6. PubMed ID: 2965122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fever in neutropenic patients: analysis of 109 episodes and 15 superinfections (author's transl)].
    Baro J; Richard C; Esteban J; Iriondo A; Conde E; Garijo J; Zubizarreta A
    Sangre (Barc); 1981; 26(4):417-26. PubMed ID: 7292225
    [No Abstract]   [Full Text] [Related]  

  • 10. Emerging bacterial resistance patterns in febrile neutropenic patients: experience at a tertiary care hospital in Pakistan.
    Khan MA; Siddiqui BK; Shamim A; Yosuf MA; Ahmed U; Zakiullah N; Burney IA
    J Pak Med Assoc; 2004 Jul; 54(7):357-60. PubMed ID: 15449917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fever in the neutropenic patient].
    Milpied N
    Rev Prat; 2001 Mar; 51(6):633-7. PubMed ID: 11345865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Application of the concepts of evidence-based medicine to the evidence on the treatment of febrile neutropenia].
    Jarque I; Sanz MA
    Enferm Infecc Microbiol Clin; 1999; 17 Suppl 2():95-102. PubMed ID: 10605194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoprophylaxis of gram-negative infections in neutropenic patients.
    Klastersky J
    Eur Urol; 1990; 17 Suppl 1():40-5. PubMed ID: 2162299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithrombin III in the diagnosis of infection in febrile neutropenic patients.
    Kibbler CC; Prentice HG; Noone P
    J Clin Microbiol; 1988 Oct; 26(10):2206-8. PubMed ID: 3183007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of serum bactericidal activity in gram-negative bacillary bacteremia in patients with and without granulocytopenia.
    Sculier JP; Klastersky J
    Am J Med; 1984 Mar; 76(3):429-35. PubMed ID: 6702874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-reactive protein for detection and follow-up of bacterial and fungal infections in severely neutropenic patients with acute leukaemia.
    Timonen TT; Koistinen P
    Eur J Cancer Clin Oncol; 1985 May; 21(5):557-62. PubMed ID: 4007021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutropenic fever syndromes in patients undergoing cytotoxic therapy for acute leukemia and myelodysplastic syndromes.
    Bow EJ
    Semin Hematol; 2009 Jul; 46(3):259-68. PubMed ID: 19549578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology and risk factors for gram-positive coccal infections in neutropenia: toward a more targeted antibiotic strategy.
    Cordonnier C; Buzyn A; Leverger G; Herbrecht R; Hunault M; Leclercq R; Bastuji-Garin S;
    Clin Infect Dis; 2003 Jan; 36(2):149-58. PubMed ID: 12522746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From the Infectious Diseases Society of America. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever.
    Hughes WT; Armstrong D; Bodey GP; Feld R; Mandell GL; Meyers JD; Pizzo PA; Schimpff SC; Shenep JL; Wade JC
    J Infect Dis; 1990 Mar; 161(3):381-96. PubMed ID: 2179420
    [No Abstract]   [Full Text] [Related]  

  • 20. Cefepime/amikacin versus ceftazidime/amikacin as empirical therapy for febrile episodes in neutropenic patients: a comparative study. The French Cefepime Study Group.
    Cordonnier C; Herbrecht R; Pico JL; Gardembas M; Delmer A; Delain M; Moreau P; Ladeb S; Nalet V; Rollin C; Gres JJ
    Clin Infect Dis; 1997 Jan; 24(1):41-51. PubMed ID: 8994754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.